Argent BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:H5O0 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Oct 24Buy€1,009,181Roby ZomerIndividual4,000,000€0.25
10 Sep 24Buy€303,794Roby ZomerIndividual1,258,500€0.24

Insider Trading Volume

Insider Buying: H5O0 insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of H5O0?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,170,4392.16%
Private Companies9,629,21817.7%
Individual Insiders12,935,14023.8%
General Public30,537,47256.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 53.2%.


Top Shareholders

Top 9 shareholders own 43.73% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.1%
Roby Zomer
9,292,320€1.4m619%no data
15.4%
Oak Capital Partners Llc
8,370,718€1.2m0%no data
3.56%
Shachar Shimony
1,933,000€286.1k2,680%no data
2.32%
Bioheka Limited
1,258,500€186.3k1,080%no data
2.06%
Yifat Steuer
1,117,194€165.4k-93.9%no data
1.83%
Spreadex.com Limited, Asset Management Arm
993,953€147.1k0%0.55%
1.09%
Amir Polak
592,626€87.7k0%no data
0.32%
Premier Fund Managers Ltd.
176,203€26.1k0%no data
0.00052%
Barclays PLC Private Banking & Investment Banking Investment
283€41.80%no data